Dixiao Zhong on Muck Rack

Dixiao Zhong

As seen in: Frontiers in Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dixiao

Contact Dixiao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification

|
By Lixiao Shi, Ruihong Tang, Xiang Cheng, Zhaoxia Zhang, Rong Liu, Dixiao Zhong, Duanfang Shao
| Frontiers in Immunology
Abstract Background: Neuroblastoma (NB) is the most common extracranial solid tumor in children, accounting for approximately 15% of pediatric oncology mortality. While risk-stratified therapy has improved survival, high-risk cases still face poor outcomes. Pretreatment inflammatory markers, including the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), have emerged as potential, cost-effective prognostic biomarkers to refine risk assessment and guide treatment intensity.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified